Normalizing HPV Vaccination in Preteens With a Serious Video Game
Normalizing Preteen HPV Vaccination With Practice-based Communication Strategies
2 other identifiers
interventional
55
1 country
1
Brief Summary
Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States and causes genital warts and cancers in both females and males. Vaccination against HPV is recommended for routine use in those aged 11-12 years old, yet is underutilized. The study's premise is that preteens are relevant decision makers who can be motivated to initiate and complete the HPV vaccine series (assuming parental consent and provider recommendation). This study evaluates a serious video game to engage preteens in the decision to pursue HPV vaccination. The hypothesis is that preteens who are assigned to the video game will be more likely to initiate and complete HPV vaccination than preteens who are not assigned to the video game.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 9, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 16, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 16, 2019
CompletedFirst Submitted
Initial submission to the registry
November 6, 2020
CompletedFirst Posted
Study publicly available on registry
November 13, 2020
CompletedNovember 13, 2020
November 1, 2020
3.8 years
November 6, 2020
November 6, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of Participants Initiating vaccination with one dose of HPV vaccine
HPV immunization records are obtained for all preteen participants from their primary care practices
approximately 9 months post intervention for each cohort total
Number of Participants completing HPV vaccination series with either 2 or 3 doses of HPV vaccine in accordance with vaccination schedule for participant
HPV immunization records are obtained for all preteen participants from their primary care practices
approximately 9 months post intervention for each cohort total
Secondary Outcomes (5)
Mean HPV Vaccination Knowledge Scale Score (5 items, range 1-3) is collected from both intervention and comparison group participants via Qualtrics surveys; higher score indicates greater knowledge of HPV and HPV vaccination
Baseline and postintervention surveys 4 months apart
Mean HPV Vaccination Self-Efficacy Scale Score (8 items, range 1-3) is collected from both intervention and comparison group participants via Qualtrics surveys; higher score indicates greater confidence in getting HPV vaccination
Baseline and postintervention surveys 4 months apart
Mean HPV Vaccination Decisional Balance Scale Score (4 items pro and 5 items con, range 1-3) is collected from intervention and comparison group participants via Qualtrics surveys; higher pro mean score and lower con mean score indicate greater support
Baseline and postintervention surveys 4 months apart
Number of participants who evaluate video game characteristics via PENS: Physical/Emotional/Narrative Presence Scale (27 items) is collected from intervention group via Qualtrics; higher score indicates agreement with video game characteristic
Postintervention survey (4 months after completing baseline survey)
Number of participants who self-report characteristics of video game play (18 items) is collected from intervention group via Qualtrics; higher score indicates report of video game characteristic
Postintervention survey (4 months after completing baseline survey)
Study Arms (2)
Video Game
ACTIVE COMPARATORThis arm tests use of video game to help preteens in the decision to pursue HPV vaccination. Participants in the intervention group are asked to play the Land of Secret Gardens game and complete 3 tasks: (1) play a shield game with blue spikey virus balls, (2) find hidden objects in 4 different garden sheds, and (3) create a potion (vaccine). Participants in the intervention arm are asked to respond to surveys about HPV and HPV vaccine knowledge, vaccination self-efficacy and decisional balance, the Physical/Emotional/Narrative Presence Scale (PENS) to gauge preteens' immersion in the game, and game play experience.
No Video Game
NO INTERVENTIONThis arm does not test the video game. Participants in the comparison arm are asked to respond to surveys about HPV and HPV vaccine knowledge, vaccination self-efficacy and decisional balance.
Interventions
An educational video game developed for 11-12 year olds to increase interest in and decision to pursue HPV vaccination.
Eligibility Criteria
You may qualify if:
- preteens 11-12 who had not received any doses of HPV vaccination
- recruited by primary care practices in North Carolina
- parent signed HIPAA release
- willing to take baseline and postintervention surveys
- access to internet and mobile device or personal computer
You may not qualify if:
- preteens who had received at least one dose of HPV vaccine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Joan R, Cates
Chapel Hill, North Carolina, 27599-3365, United States
Related Publications (2)
Cates JR, Fuemmeler BF, Diehl SJ, Stockton LL, Porter J, Ihekweazu C, Gurbani AS, Coyne-Beasley T. Developing a Serious Videogame for Preteens to Motivate HPV Vaccination Decision Making: Land of Secret Gardens. Games Health J. 2018 Feb;7(1):51-66. doi: 10.1089/g4h.2017.0002. Epub 2017 Nov 21.
PMID: 29161529BACKGROUNDCates JR, Fuemmeler BF, Stockton LL, Diehl SJ, Crandell JL, Coyne-Beasley T. Evaluation of a Serious Video Game to Facilitate Conversations About Human Papillomavirus Vaccination for Preteens: Pilot Randomized Controlled Trial. JMIR Serious Games. 2020 Dec 3;8(4):e16883. doi: 10.2196/16883.
PMID: 33270028DERIVED
Study Officials
- STUDY DIRECTOR
Bernard F. Fuemmeler, PhD
Virginia Commonwealth University
- STUDY DIRECTOR
Jamie L. Crandell, PhD
University of North Carolina, Chapel Hill
- PRINCIPAL INVESTIGATOR
Joan Cates, PhD
University of North Carolina, Chapel Hill
- STUDY DIRECTOR
Sandra J Diehl, MPH
University of North Carolina, Chapel Hill
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- On enrollment, participants randomly assigned to condition.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 6, 2020
First Posted
November 13, 2020
Study Start
July 9, 2015
Primary Completion
April 16, 2019
Study Completion
April 16, 2019
Last Updated
November 13, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share